These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 326076)

  • 1. The value of lactic dehydrogenase as a predictor of early allograft survival.
    Roses J; Woods JE; Zincke H
    Am J Surg; 1977 Jun; 133(6):726-8. PubMed ID: 326076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lactic dehydrogenase and human renal allograft failure.
    Anderson CB; Codd JE; Graff RJ; Gregory JG; Groce MA; Newton WT
    Surgery; 1975 May; 77(5):674-9. PubMed ID: 1092021
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of the determination of lactic dehydrogenase (LDH) after renal transplantation].
    Ianhez LE; da Costa RA; Sabbaga E
    Rev Hosp Clin Fac Med Sao Paulo; 1980 Feb; 35(1):9-12. PubMed ID: 6996069
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum hippuric acid concentration in renal allograft rejection, ureter obstruction, and tubular necrosis.
    Knoflach A; Binswanger U
    Transpl Int; 1994; 7(1):17-21. PubMed ID: 8117397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lactic dehydrogenase and irreversible renal allograft rejection.
    Anderson CB; Groce MA; Mohapatra RN; Codd JE; Graff RJ; Gregory JG; Newton WT
    Surgery; 1976 Feb; 79(02):161-5. PubMed ID: 1108256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Lactate Dehydrogenase is Elevated in Ischemic Acute Tubular Necrosis but Not in Acute Rejection in Kidney Transplant Patients.
    Green H; Tobar A; Gafter-Gvili A; Leibovici L; Klein T; Rahamimov R; Mor E; Grossman A
    Prog Transplant; 2017 Mar; 27(1):53-57. PubMed ID: 27555073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum levels of lactic dehydrogenase after renal transplants].
    de Lima JJ; do Amaral Torres JN; da Rocha AL; Saldanha RV
    AMB Rev Assoc Med Bras; 1978 Aug; 24(8):262-4. PubMed ID: 364556
    [No Abstract]   [Full Text] [Related]  

  • 8. A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Najarian JS; Fryd DS; Strand M; Canafax DM; Ascher NL; Payne WD; Simmons RL; Sutherland DE
    Ann Surg; 1985 Feb; 201(2):142-57. PubMed ID: 3882063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allograft viability determined by enzyme analysis.
    Codd JE; Garvin PJ; Morgan R; Jellinek M; Newton WT
    Transplantation; 1979 Dec; 28(6):447-50. PubMed ID: 390783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum & urinary interleukin-2 levels as predictors in acute renal allograft rejection.
    Gupta RK; Jain M; Sharma RK
    Indian J Med Res; 2004 Jan; 119(1):24-7. PubMed ID: 14997990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of B2 microglobulin in pediatric renal transplantation.
    Firlit CF; Greenslade T; Bashoor R
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():219-25. PubMed ID: 91163
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of early acute rejection with daclizumab and triple immunosuppression in cadaveric renal allograft recipients.
    Kandus A; Grego K; Bren AF
    Ther Apher Dial; 2005 Jun; 9(3):262-4. PubMed ID: 15967003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-mediated rejection: importance of lactate dehydrogenase and neutrophilia in early diagnosis.
    Khan TT; Mirza AB; Zahid R; Haleem A; Al Hussaini H; Al Sulaiman M; Mousa D
    Saudi J Kidney Dis Transpl; 2011 May; 22(3):525-30. PubMed ID: 21566312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OKT3 prophylaxis in cadaveric kidney transplant recipients with delayed graft function.
    Cohen DJ; Benvenisty AI; Cianci J; Hardy MA
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):19-27. PubMed ID: 2510507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of initial slow graft function on renal allograft rejection and survival.
    Humar A; Johnson EM; Payne WD; Wrenshall L; Sutherland DE; Najarian JS; Gillingham KJ; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):623-7. PubMed ID: 9408697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed renal function and long-term cadaver renal allograft survival.
    Anderson CB; Sicard GA; Etheredge EE
    Transplant Proc; 1979 Mar; 11(1):482-5. PubMed ID: 377680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney allograft failure in the steroid-free immunosuppression era: A matched case-control study.
    Alkadi MM; Kim J; Aull MJ; Schwartz JE; Lee JR; Watkins A; Lee JB; Dadhania DM; Seshan SV; Serur D; Kapur S; Suthanthiran M; Hartono C; Muthukumar T
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28921709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of needle renal allograft biopsy. I. A retrospective study of biopsies performed during putative rejection episodes.
    Matas AJ; Sibley R; Mauer M; Sutherland DE; Simmons RL; Najarian JS
    Ann Surg; 1983 Feb; 197(2):226-37. PubMed ID: 6297416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.